Neuroinflammation and neural activity in the olfactory bulb drives olfactory dysfunction in a rat model of eosinophilic chronic rhinosinusitis
Rhinology Journal · 2026
DOI: 10.4193/rhin25.164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, 2026. Verfasst von Z Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Olfactory Bulb, Rhinitis, Sinusitis, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Chronic rhinosinusitis (CRS) is a common cause of olfactory dysfunction (OD), and eosinophilic CRS is one of the subtypes characterized by eosinophilic infiltration. Animal models of olfactory dysfunction in eosinophilic CRS are necessary for exploring potential therapeutic strategies. Glucocorticoids are therapeutic for eosinophilic CRS-OD and the mechanism of action requires further exploration. Methodology: The eosinophilic CRS-OD rat model was induced by intranasal administration of oval-bumin (OVA) and Aspergillus oryzae protease (AP) for 8 weeks, followed by intraperitoneal injection of dexamethasone. Olfactory function was assessed behaviorally, neuronal activity electrophysiologically, and neurotransmitter/inflammatory factor levels via high-performance liquid chromatography (HPLC). Histological analyses of nasal tissue and the olfactory bulb were performed.
Results
All OVA/AP-induced eosinophilic CRS-OD rats developed chronic nasal inflammation and olfactory dysfunction. Reduced olfactory bulb (OB) volume was accompanied by thinning of the olfactory neuron layer (ONL) and the glomerular layer (GL). The OB exhibited increased microglia and elevated inflammatory cytokine expression. Further analysis revealed decreased glutamate (Glu), increased γ-aminobutyric acid (GABA), and a significant reduction in the spontaneous firing rate (SFR) of mitral/tufted cells (M/Ts) within the OB. Dexamethasone treatment significantly ameliorated olfactory impairment in this model, decreasing OB microglia numbers and inflammatory cytokine levels, and significantly increasing M/T SFR.
Conclusions
Microglia-mediated neuroinflammation contributes to abnormal neural activity in the olfactory bulb, which may be one mechanism for the develop-ment of eosinophilic CRS-OD. The neuroprotective effect of dexamethasone, mediated through microglial inhibition, highlights microglia as an important therapeutic target for eosinophilic CRS-OD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Peking University Third Hospital, Beijing, China.
- Department of Otolaryngology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zitieren
APA
Zhang, Z., Du, Y., Xiong, S., Cao, W., Jiang, H., Wang, J., Li, M., Hu, Y., Ma, F., & Zhang, Y. (2026). Neuroinflammation and neural activity in the olfactory bulb drives olfactory dysfunction in a rat model of eosinophilic chronic rhinosinusitis. Rhinology Journal. https://doi.org/10.4193/rhin25.164
Vancouver
Zhang Z, Du Y, Xiong S, Cao W, Jiang H, Wang J, et al. Neuroinflammation and neural activity in the olfactory bulb drives olfactory dysfunction in a rat model of eosinophilic chronic rhinosinusitis. Rhinology Journal. 2026. doi:10.4193/rhin25.164
BibTeX
@article{Zhang2026,
author = {Zhang, Z and Du, Y and Xiong, S and Cao, W and Jiang, H and Wang, J and Li, M and Hu, Y and Ma, F and Zhang, Y},
title = {Neuroinflammation and neural activity in the olfactory bulb drives olfactory dysfunction in a rat model of eosinophilic chronic rhinosinusitis},
journal = {Rhinology Journal},
year = {2026},
doi = {10.4193/rhin25.164}
}
EUVIMED